OSCE stationDrNB Cardiology – Viva master list

Procedures & devices viva list

21 cases · 105 viva questionsLast reviewed: October 2026
Merit MedScript seal

Pacemakers, defibrillators and CRT, structural and valve devices, balloon pumps and circulatory support, cath-lab views, lines and tubes — as they appear on the chest film and in the cath lab. Each entry tells you what to point at, the diagnosis, the risk and the next step, followed by five examiner cross-examination questions.

How to present in the viva: Name the device and its position first (generator, leads, tip), then check it is where it should be, name one complication you would look for on this film, and finish with the next step.

APacemakers & defibrillators

1.Permanent pacemaker

  • What to point at: Generator in the pre-pectoral pocket with thin leads to the RA appendage and/or the RV (apex, septum or conduction system).
  • Diagnosis: Single- or dual-chamber pacemaker
  • Clinical risk: Lead dislodgement, pocket haematoma or infection, pneumothorax, perforation.
  • Management: Device interrogation: battery, lead impedance, sensing and capture thresholds.
Viva questions (5)
  • Q: How do you spot an active-fixation lead?A: A small deployed helix (screw) at the lead tip.
  • Q: Twiddler syndrome?A: Patient rotates the generator, coiling and dislodging the leads.
  • Q: Most physiological ventricular pacing site?A: Conduction-system pacing (His bundle or left bundle branch area); RV septal pacing has not proven better than apical.
  • Q: First letter of the NBG code?A: Chamber paced (A, V, D or O).
  • Q: MRI?A: Only if the whole system (generator and leads) is MR-conditional, with programming to a safe mode before scanning.

2.Implantable cardioverter-defibrillator

  • What to point at: Thick radio-opaque shock coil(s) on the RV lead — in the RV, with or without a second coil in the SVC.
  • Diagnosis: Transvenous ICD
  • Clinical risk: Inappropriate shocks, lead fracture, infection.
  • Management: Interrogation with review of stored electrograms, sensing and therapy zones.
Viva questions (5)
  • Q: Single vs dual coil?A: Single coil in the RV; dual coil adds a proximal coil in the SVC.
  • Q: Secondary-prevention indication?A: Survivor of VF arrest or haemodynamically unstable VT without a reversible cause.
  • Q: Effect of a magnet?A: Suspends tachyarrhythmia therapies but does not change the pacing mode (in most devices).
  • Q: What is an S-ICD?A: Parasternal subcutaneous lead with a left lateral generator; no intravascular leads, no bradycardia pacing.
  • Q: Commonest cause of inappropriate shocks?A: AF or other SVT with fast ventricular rates; also T-wave oversensing and lead noise.

3.Cardiac resynchronisation therapy

  • What to point at: Three leads: RA, RV and an LV lead through the coronary sinus into a lateral or posterolateral vein.
  • Diagnosis: CRT (biventricular) device
  • Clinical risk: Phrenic nerve stimulation, CS dissection, lead dislodgement, non-response.
  • Management: Ensure >98% biventricular pacing; optimise AV/VV timing and GDMT.
Viva questions (5)
  • Q: Target vein?A: Lateral or posterolateral coronary sinus branch.
  • Q: Class I ECG indication?A: LBBB with QRS ≥150 ms, LVEF ≤35% on GDMT, sinus rhythm.
  • Q: How do you know the LV lead captures?A: The paced QRS narrows, often with a dominant R in V1 and Q in lead I.
  • Q: Non-responder rate?A: About 30%.
  • Q: Diaphragmatic twitching?A: Phrenic nerve capture — commonest with lateral, posterolateral or apical positions; reprogram the vector or reposition.

4.Implantable loop recorder

  • What to point at: Small rectangular radio-opaque device subcutaneously over the left chest, without leads.
  • Diagnosis: Implantable loop recorder (ILR)
  • Clinical risk: Infection, missed events, data overload.
  • Management: Remote monitoring for pauses, AV block, AF or tachycardia.
Viva questions (5)
  • Q: Battery life?A: About 3–4.5 years.
  • Q: Indications?A: Recurrent unexplained syncope; AF detection after cryptogenic stroke.
  • Q: Leads?A: None.
  • Q: How are events captured?A: Automatically by programmed criteria, or by the patient activator.
  • Q: MRI?A: Modern ILRs are MR-conditional.

BStructural & valve devices

5.Septal occluder (Amplatzer)

  • What to point at: Double-disc nitinol mesh projected over the interatrial septum.
  • Diagnosis: Transcatheter ASD closure device
  • Clinical risk: Embolisation, erosion (aortic root), residual shunt, arrhythmia, thrombus.
  • Management: Aspirin (± clopidogrel) for about 6 months; endocarditis prophylaxis for 6 months; echo follow-up.
Viva questions (5)
  • Q: Which ASD suits a device?A: Secundum ASD with adequate rims.
  • Q: Rim requirement?A: About ≥5 mm on all sides except the retro-aortic rim, which may be deficient.
  • Q: Most feared late complication?A: Erosion into the aortic root or atrial wall causing tamponade.
  • Q: When is endothelialisation complete?A: About 6 months.
  • Q: Material?A: Nitinol; nickel allergy is a rare relative contraindication.

6.PTMC with the Inoue balloon

  • What to point at: Hour-glass (dumbbell) Inoue balloon across the mitral valve after transseptal puncture.
  • Diagnosis: Percutaneous transvenous mitral commissurotomy
  • Clinical risk: Severe MR, tamponade from septal puncture, embolism.
  • Management: Immediate echo for MR and gradient; LA pressure fall.
Viva questions (5)
  • Q: Ideal Wilkins score?A: 8 or less (with no significant commissural calcification).
  • Q: Contraindications?A: LA thrombus, MR more than mild-to-moderate, MVA >1.5 cm², severe or bicommissural calcification.
  • Q: Inflation sequence?A: Distal half first, then proximal, then the waist — splitting the commissures.
  • Q: Balloon size?A: From height: height (cm)/10 + 10 mm.
  • Q: Success?A: MVA ≥1.5 cm² (or ≥50% increase) without MR >2+.

7.MitraClip (TEER)

  • What to point at: Small metallic clip(s) grasping the anterior and posterior mitral leaflets.
  • Diagnosis: Mitral transcatheter edge-to-edge repair
  • Clinical risk: Single-leaflet device attachment, iatrogenic mitral stenosis, residual MR.
  • Management: TEE-guided implantation; check transmitral gradient after each clip.
Viva questions (5)
  • Q: Surgical equivalent?A: Alfieri edge-to-edge stitch.
  • Q: Classic target?A: A2–P2.
  • Q: Gradient limit?A: Mean gradient ≤5 mmHg.
  • Q: Indications?A: Severe primary MR at high surgical risk, or severe secondary MR meeting COAPT criteria on GDMT.
  • Q: Route?A: Femoral vein with transseptal puncture.

8.Mechanical prosthetic valve

  • What to point at: Radio-opaque valve: caged ball (Starr–Edwards), tilting disc (Medtronic Hall) or bileaflet (St Jude).
  • Diagnosis: Mechanical prosthesis
  • Clinical risk: Valve thrombosis, bleeding, haemolysis, endocarditis.
  • Management: Lifelong vitamin K antagonist with INR targets by valve and patient risk.
Viva questions (5)
  • Q: Target INR — modern bileaflet aortic, no risk factors?A: 2.5 (range 2.0–3.0).
  • Q: Mitral or with risk factors?A: 3.0 (range 2.5–3.5).
  • Q: DOACs?A: Contraindicated (RE-ALIGN, PROACT Xa).
  • Q: Auscultatory sign of thrombosis?A: Muffled or absent closing clicks.
  • Q: Pannus vs thrombus?A: Pannus: small, dense, slowly progressive. Thrombus: larger, soft, recent onset, often subtherapeutic INR.

9.Transcatheter aortic valve

  • What to point at: Large metallic stent frame (balloon-expandable or self-expanding) housing a tissue valve in the aortic position.
  • Diagnosis: TAVI prosthesis
  • Clinical risk: Heart block, paravalvular leak, stroke, annular rupture, coronary obstruction.
  • Management: Lifelong single antiplatelet if no OAC indication (POPular TAVI); ECG monitoring for new LBBB or AV block.
Viva questions (5)
  • Q: Two main types?A: Balloon-expandable (Sapien) and self-expanding (Evolut).
  • Q: Higher pacemaker rate?A: Self-expanding valves (deeper LVOT implantation).
  • Q: Cause of paravalvular leak?A: Heavy annular calcium, undersizing or malposition.
  • Q: Coronary obstruction?A: Displaced native leaflet covers the ostium — risk with low coronary height and narrow sinuses.
  • Q: Durability?A: Comparable to surgical bioprostheses out to about 10 years in available trials.

10.Watchman (LAA occluder)

  • What to point at: Parachute- or umbrella-shaped nitinol frame within the LAA on fluoroscopy or CXR.
  • Diagnosis: Left atrial appendage occlusion device
  • Clinical risk: Pericardial effusion or tamponade, embolisation, device-related thrombus, peri-device leak.
  • Management: Short-term OAC or DAPT after implant per protocol, TEE or CT at ~45 days, then single antiplatelet.
Viva questions (5)
  • Q: Indication?A: Non-valvular AF with high stroke risk and a contraindication to long-term anticoagulation (ESC 2024: Class IIb).
  • Q: PASS criteria?A: Position, Anchor (tug test), Size (compression), Seal (no leak >5 mm).
  • Q: Access?A: Transseptal puncture, inferior and posterior on the septum.
  • Q: Imaging guidance?A: TEE (or ICE) with fluoroscopy.
  • Q: Undersized device?A: Embolisation (to LV or aorta) and peri-device leak.

11.Melody transcatheter pulmonary valve

  • What to point at: Bovine jugular venous valve inside a platinum-iridium stent in the RVOT/conduit, often inside pre-stents.
  • Diagnosis: Transcatheter pulmonary valve (Melody)
  • Clinical risk: Stent fracture, endocarditis, coronary compression, conduit rupture.
  • Management: Echo follow-up of gradient and regurgitation; endocarditis prophylaxis and dental hygiene.
Viva questions (5)
  • Q: Commonest indication?A: Dysfunctional RV–PA conduit (e.g. repaired ToF, Ross).
  • Q: Key pre-implant test?A: Coronary compression testing — balloon in the conduit with simultaneous coronary angiography.
  • Q: Coronary at risk?A: The left coronary/LAD, especially with an anomalous course.
  • Q: Particular complication?A: Infective endocarditis (higher than surgical valves).
  • Q: Prevent stent fracture?A: Pre-stenting the conduit.

CCirculatory support & cath views

12.Intra-aortic balloon pump

  • What to point at: Radio-opaque tip about 2 cm below the left subclavian origin — at the level of the aortic knob/2nd–3rd intercostal space on CXR.
  • Diagnosis: IABP
  • Clinical risk: Limb ischaemia, vascular injury, thrombocytopenia, malposition.
  • Management: 1:1 counterpulsation triggered from ECG or arterial pressure; daily CXR for position.
Viva questions (5)
  • Q: Haemodynamic effect?A: Diastolic inflation raises coronary perfusion; presystolic deflation lowers afterload.
  • Q: When does it inflate?A: At the dicrotic notch (aortic valve closure).
  • Q: Contraindications?A: Moderate-to-severe AR, aortic dissection, severe aorto-iliac disease.
  • Q: Too low?A: Renal or mesenteric occlusion.
  • Q: Too high?A: Left subclavian or carotid occlusion — diminished left radial pulse.

13.Pulmonary artery catheter — correct position

  • What to point at: Catheter through the RA and RV with the tip in a proximal right or left PA, within about 2 cm of the hilum.
  • Diagnosis: Swan–Ganz catheter
  • Clinical risk: PA rupture, pulmonary infarction, arrhythmia, infection.
  • Management: Keep the balloon deflated except during wedge measurement.
Viva questions (5)
  • Q: What does PCWP estimate?A: Left atrial pressure (and LVEDP if the mitral valve is normal).
  • Q: Ideal lung zone?A: West zone 3.
  • Q: Too distal on CXR?A: Tip far out towards the periphery — risk of infarction and rupture.
  • Q: Indications?A: Mixed or unclear shock, cardiogenic shock management, PH work-up, transplant evaluation.
  • Q: Normal cardiac index?A: 2.5–4.0 L/min/m².

14.Pulmonary artery catheter — malpositioned

  • What to point at: Tip coiled or ending in the RV shadow.
  • Diagnosis: Malpositioned PA catheter
  • Clinical risk: VT, ventricular ectopy, RBBB, RV perforation.
  • Management: Advance with the balloon inflated or withdraw to the RA with the balloon deflated.
Viva questions (5)
  • Q: RV waveform?A: Systolic ~25 mmHg with diastolic pressure falling to near zero.
  • Q: Why arrhythmogenic?A: Mechanical irritation of the RV and right bundle.
  • Q: RA waveform?A: Low pressure with a, c and v waves.
  • Q: PA waveform?A: Systolic similar to RV but diastolic step-up with a dicrotic notch (e.g. 25/10).
  • Q: Bedside confirmation?A: Waveform transitions during advancement.

15.Impella

  • What to point at: Catheter crossing the aortic valve: pigtail in the LV, inlet about 3.5 cm below the aortic annulus, outlet in the ascending aorta.
  • Diagnosis: Microaxial flow pump (Impella CP or 5.5)
  • Clinical risk: Haemolysis, limb ischaemia, bleeding, aortic valve injury, migration.
  • Management: Echo to confirm position; heparin purge; monitor haemolysis (LDH, plasma free Hb) and limb perfusion.
Viva questions (5)
  • Q: How does it work?A: Continuous axial-flow pump aspirating from the LV and ejecting into the ascending aorta.
  • Q: Effect on the LV?A: Direct unloading — lowers LVEDP, wall stress and myocardial oxygen demand.
  • Q: Too deep?A: Outlet falls inside the LV — recirculation, no effective support, possible mitral apparatus injury.
  • Q: Pulled back into the aorta?A: Inlet in the aorta — loss of support; malposition and suction cause haemolysis.
  • Q: Contraindications?A: LV thrombus, mechanical aortic valve, moderate–severe AR, severe peripheral arterial disease.

16.Coronary angiogram — LAO caudal (spider) view

  • What to point at: LAO 40–50° with caudal 20–30°: left main dividing into LAD, LCx (and ramus) like spider legs.
  • Diagnosis: Left main bifurcation view
  • Clinical risk: Missed ostial or bifurcation disease if not imaged well.
  • Management: Assess LM and bifurcation disease; Heart Team decision (SYNTAX).
Viva questions (5)
  • Q: Typical angles?A: LAO 40–50°, caudal 20–30°.
  • Q: Why ‘spider’?A: LM and its branches resemble spider legs.
  • Q: Best for?A: LM bifurcation, proximal LAD and LCx.
  • Q: Limitation?A: Foreshortens the mid and distal LAD.
  • Q: Deep catheter engagement misses?A: Left main ostial disease.

17.Coronary angiogram — RAO cranial view

  • What to point at: RAO 10–30° with cranial 30–40°: LAD running to the apex with diagonals and septals separated.
  • Diagnosis: LAD and diagonal view
  • Clinical risk: Missed mid-LAD or diagonal ostial disease.
  • Management: Use with LAO cranial to assess LAD–diagonal bifurcations.
Viva questions (5)
  • Q: Typical angles?A: RAO 10–30°, cranial 30–40°.
  • Q: Best for?A: Mid and distal LAD and diagonal origins.
  • Q: Septal branches?A: Straight, short, non-tortuous branches running into the septum.
  • Q: LAD vs LCx?A: The LAD reaches the apex; the LCx stays in the AV groove.
  • Q: Left main?A: Poorly seen — foreshortened.

18.VA-ECMO cannulae

  • What to point at: Large venous drainage cannula (femoral vein to RA/IVC junction) and arterial return cannula in the femoral artery/iliac aorta.
  • Diagnosis: Veno-arterial ECMO
  • Clinical risk: LV distension, differential (Harlequin) hypoxaemia, limb ischaemia, bleeding, stroke.
  • Management: LV venting if distended (Impella or IABP), distal perfusion cannula, monitor right radial saturation.
Viva questions (5)
  • Q: Purpose?A: Combined circulatory and respiratory support.
  • Q: Why does the LV distend?A: Retrograde aortic flow raises afterload; a failing LV may not open the aortic valve.
  • Q: Harlequin syndrome?A: Recovering heart ejects poorly oxygenated blood to the upper body while ECMO blood supplies the lower body.
  • Q: Prevent leg ischaemia?A: Antegrade distal perfusion cannula in the superficial femoral artery.
  • Q: VA vs VV?A: VV supports gas exchange only; VA supports the circulation as well.

DLines & tubes

19.Central venous catheter

  • What to point at: Radio-opaque line with the tip at the cavo-atrial junction (lower SVC).
  • Diagnosis: Central venous catheter
  • Clinical risk: Pneumothorax, arterial puncture, arrhythmia, infection (CLABSI), thrombosis.
  • Management: CXR to confirm position and exclude pneumothorax before use.
Viva questions (5)
  • Q: Where is the cavo-atrial junction?A: About two vertebral bodies (3–4 cm) below the carina.
  • Q: Tip too deep?A: Arrhythmia and perforation risk.
  • Q: Lowest infection risk site?A: Subclavian.
  • Q: Coagulopathy?A: Ultrasound-guided internal jugular or femoral (compressible).
  • Q: Arterial vs venous?A: Arterial course follows the aortic arch to the left; confirm by pressure transduction or blood gas.

20.Endotracheal tube

  • What to point at: Tube tip about 5 cm (3–7 cm) above the carina with the neck neutral.
  • Diagnosis: Endotracheal tube position
  • Clinical risk: Right main bronchus intubation, oesophageal intubation, cord injury.
  • Management: Auscultation and capnography; withdraw if endobronchial.
Viva questions (5)
  • Q: Carina level?A: T4–T5.
  • Q: Why the right main bronchus?A: Wider, shorter and more vertical.
  • Q: Consequence?A: Left lung collapse and right hyperinflation.
  • Q: Neck flexion?A: Tip moves down.
  • Q: Neck extension?A: Tip moves up.

21.Nasogastric tube

  • What to point at: Tube in the midline down the oesophagus, bisecting the carina, crossing the diaphragm, with the tip in the stomach ≥10 cm beyond the gastro-oesophageal junction.
  • Diagnosis: Nasogastric tube position
  • Clinical risk: Tracheobronchial placement, aspiration, pneumothorax.
  • Management: Confirm before feeding: aspirate pH ≤5.5, or CXR if pH testing fails.
Viva questions (5)
  • Q: Danger sign on CXR?A: Tube following a bronchus into the lung.
  • Q: Whoosh test?A: Unreliable — never use it.
  • Q: What is a Dobhoff tube?A: Fine-bore weighted-tip feeding tube, often placed post-pylorically.
  • Q: Long-term complication?A: Oesophagitis, ulceration, stricture, sinusitis.
  • Q: Guidewire?A: Leave it in until position is confirmed; never reinsert it while the tube is in situ.

Classes and cut-offs follow the ESC 2020–2024 and ACC/AHA guidelines current in October 2026; always apply your own institution's protocols.

meritmedscript.comDr. Sidhartha Mullapudi